SCHEMBL2194664

SCHEMBL2194664

CCC(CO)(CO)C(O)CCC(CO)(CO)CO

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL224173 0.89 DPP4 (0.31) DPP4
SCHEMBL28477505 0.81 TSHR (0.35) DPP4
SCHEMBL4995532 0.76 TSHR (0.35) DPP4
SCHEMBL18938915 0.76 LMNA (0.31) DPP4
SCHEMBL15044071 0.75 TSHR (0.33) DPP4
SCHEMBL9521759 0.75 TSHR (0.46) DPP4
SCHEMBL14142540 0.74
SCHEMBL8103459 0.73 THRB (0.40) DPP4
SCHEMBL7596325 0.72 LMNA (0.34)
SCHEMBL27929543 0.72 ALDH1A1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2875181-A1 COMPOSITE SHEET MATERIAL, METHOD FOR THE PRODUCTION AND USE THEREOF Benecke-Kaliko AG (DE) 2015-05-27 EP disclosed
EP-2875180-A1 COMPOSITE SHEET MATERIAL, METHOD FOR THE PRODUCTION AND USE THEREOF Benecke-Kaliko AG (DE) 2015-05-27 EP disclosed
WO-2014012710-A1 COMPOSITE SHEET MATERIAL, METHOD FOR THE PRODUCTION AND USE THEREOF BENECKE-KALIKO AG (DE) 2014-01-23 WO disclosed
WO-2014012719-A1 COMPOSITE SHEET MATERIAL, METHOD FOR THE PRODUCTION AND USE THEREOF BENECKE-KALIKO AG (DE) 2014-01-23 WO disclosed
US-20110171112-A1 BORON OR ALUMINUM COMPLEXES UNIVERSITE DE PICARDIE JULES VERNE (FR) 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110171112-A1 BORON OR ALUMINUM COMPLEXES AFF4, AFF2, AFF1 DPP4 4038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.